Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastrin with Islet Transplantation for Type 1 Diabetes
NCT03746769Phase 2Recruiting
- Sponsor
- City of Hope
- Start
- May 2019
- Primary completion
- Aug 2028
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of gastrin 17 in type 1 diabetes mellitus (T1D), sponsored by City of Hope. Started May 2019; status: recruiting.
02
Drugs
gastrin 17
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03746769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03746769.